XAV939 stabilizes AXIN

Summary
Organism
Homo sapiens (human)
Reactome
R-HSA-5545619
PubChem
R-HSA-5545619
Description
  • XAV939 binds to the catalytic sites of tankyrase 1 and 2 and inhibits the ADP-ribosylation of AXIN1 and 2. Treatment of cells with XAV939 significantly increases the protein, but not the mRNA levels of AXIN1 and 2 and supports a strong increase in the level of GSK3beta-AXIN complexes. These cells also show increased phosphorylation of beta-catenin, decreased beta-catenin protein levels and a corresponding decrease in beta-catenin dependent transcription. Treatment of DLD-1 cells with XAV939 has also been shown to inhibit proliferation (Huang et al, 2009). XAV939 has not been tested in a clinical setting.
Click on a node on the pathway to see its details. Glycoproteins are marked with a glycoprotein icon in their name.
Displaying all 2 entries
UniProt ID Protein Name Gene Symbol Pathway Viewer
O95271 Poly [ADP-ribose] polymerase tankyrase-1
  • PARP5A
  • PARPL
  • TIN1
  • TINF1
  • TNKS
  • TNKS1
view
Q9H2K2 Poly [ADP-ribose] polymerase tankyrase-2
  • PARP5B
  • TANK2
  • TNKL
  • TNKS2
view

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: [email protected]

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.5.0

Last updated: April 6, 2026